study question: Are urinary phthalate concentrations associated with altered semen quality parameters among males recruited from the general population?
Introduction
Phthalate diesters are used broadly in consumer products, leading to widespread human exposure and concern about potential implications for human health. These organic compounds have long been used as plasticizers in a myriad of commercial applications (Wittassek et al., 2011; Guo and Kannan, 2013) . High molecular weight phthalates, such as di-(2-ethylhexyl) phthalate (DEHP) and di-isononyl phthalate (DNP), are incorporated into applications that utilize flexible vinyl plastics, whereas low molecular weight phthalates, such as dibutyl phthalate (DBP) and diethyl phthalate (DEP), are used as solvents and coatings (Hauser and Calafat, 2005; Guo and Kannan, 2013) . Once absorbed, phthalate diesters are quickly metabolized into monoesters, which are biologically active and ultimately excreted in urine where they can be measured. Phthalates are considered to be ubiquitous in the modern environment, and human exposure frequently occurs through ingestion of foods contaminated by phthalates used in packaging, coatings used in medications, and solvents used in personal care products (Koch et al., 2013) . Human biomonitoring data suggest that measurable levels of phthalate are common in the general US population (CDC, 2015) .
A growing body of evidence, animal and human, suggests effects of phthalates on male reproductive function (Foster, 2006; Kay et al., 2014) . Male rodents exposed to non-toxic doses of DEHP and DBP in utero, and during the early post-natal period, have displayed antiandrogenic effects (Foster et al., 2001; Miura et al., 2007) and reduced testosterone production (Parks et al., 2000) , although these effects have not been observed uniformly. Conversely, marmosets with fetal and neonatal exposure to DEHP and monobutyl phthalate (MBP) have displayed neither short-term nor long-term effects on hormone production or reproductive physiology (Tomonari et al., 2006; McKinnell et al., 2009) . Results from in vitro testicular tissue explant studies are likewise discordant; impaired steroidogenesis and severe germ cell dysfunction have been reported for rat specimens, but not for human specimens treated with DBP (Heger et al., 2012; Mitchell et al., 2012) , although testosterone synthesis was decreased by DEHP (Desdoits-Lethimonier et al., 2012) . The results from human epidemiologic studies of sexsteroid hormones have also been inconsistent (Meeker et al., 2009; Meeker and Ferguson, 2014) .
Data in human populations are limited with respect to phthalates and male reproductive health, and largely rely on men/couples seeking infertility evaluation or treatment (Kay et al., 2014) . Such findings include MBP being associated with lower sperm concentration and poorer morphology, and monoethyl phthalate (MEP) being associated with sperm DNA damage, and similarly so, for mono-(2-ethylhexyl) phthalate (MEHP) after adjustment for other DEHP metabolites (Hauser et al., 2007) . However, no such associations have been observed in studies evaluating phthalates and semen quality among non-clinical samples in Sweden (Jö nsson et al., 2005) , Denmark (Joensen et al., 2012) and China (Han et al., 2014) , raising questions about the generalizability of findings from clinical settings to populations. Another limitation of past research is the reliance on a few semen quality end-points such as sperm concentration, count and morphology (Kay et al., 2014) , which are reported to have limited clinical value in the absence of extremes (Lewis, 2007) . Other challenges include the wide spectrum of biologically active primary and secondary metabolites of phthalates, with apparently heterogeneous effects (Hauser and Calafat, 2005) .
Thus, the objective of our study was to evaluate the impact of phthalate diester exposure on male reproductive health using a non-clinical sample of males and a broad panel of measures of semen quality. We sought to explore the relation between phthalate concentrations and a diverse array of semen quality end-points in men recruited from the general population.
Materials and Methods

Study sample
The current analysis was performed using data from male participants in the Longitudinal Study of Infertility and the Environment (LIFE), a prospective cohort study that enrolled couples discontinuing contraception to conceive a pregnancy, the details of which have been previously published (Buck Louis et al., 2011) . In brief, a total of 501 couples were recruited from 16 counties at study sites in Michigan and Texas from 2005 to 2009; 42% of couples who completed screening and were eligible to participate enrolled in the study. Because of the absence of uniform registries of couples planning pregnancy to use as a sampling frame (Buck et al., 2004) , the Texas fishing/hunting license registry and a commercial marketing database in Michigan were used to identify potential participants. Eligible men were aged at least 18 years, in a committed relationship, and capable of communication in English or Spanish. Men with physician-diagnosed infertility were ineligible for participation.
We conducted baseline interviews in participants' homes at the time of enrollment, took anthropometric measurements, and collected biologic specimens. Nurse interviewers collected information regarding demographics, health and reproductive histories, physical activity, and medication/supplement use. Non-fasting blood and spot urine specimens were collected at the time of the baseline interview, and the specimens were stored on ice until transportation to study site laboratories for storage at 2808C.
The study protocol entailed collection of two semen samples: one at baseline and another after one month, as has been described in detail previously (Buck Louis et al., 2015) . Home collection kits were provided, which included insulated shipping containers, shipping materials, cold packs, and glass specimen jars with an attached thermometer. The men were instructed to collect semen samples by masturbation following two days of abstinence and without use of lubricants. Men recorded the date and time of collection on the label of the specimen, noted if any sample was spilled (yes/no), and noted the length of abstinence or time since last ejaculation in days. Semen was shipped on cold packs overnight, arriving at the andrology laboratory for analysis the next day.
Semen quality assessment
Thirty-four semen quality parameters were assessed by the National Institute of Occupational Safety and Health (NIOSH) Andrology Laboratory (Cincinnati, OH, USA). Upon arrival at the lab, semen specimens were checked to verify temperature between 20.5 and 158C, and then warmed to 378C. Volume was measured to the nearest 0.1 ml and viability was determined using the hypo-osmotic swelling (HOS) assay (Jeyendran et al., 1992) . A semen aliquot was placed into a 20-mm-depth micro chamber slide (Leja, Nieuw-Vennep, Netherlands) and eight measures of motility were determined using the HTM-IVOS computer aided semen analysis (CASA) platform with video playback (Hamilton Thorne Biosciences, Beverly, MA, USA). Azoospermia denoted the absence of sperm in both samples, and such men were informed and advised to seek clinical care.
For each semen specimen, four standard microscopic slides were prepared with IDENT TM stain by Fertility Solutions w (Cleveland, OH, USA). IDENT TM slides were used to determine sperm total count and concentration using the HTM-IVOS CASA platform (Hamilton Thorne Biosciences), and also to assess 14 measures of sperm morphology and 6 measures of sperm head morphometry (Schrader et al., 1990) using the IVOS METRIX system (Hamilton Thorne Biosciences). For overall sperm morphology, we applied both the third edition of the World Health Organization (WHO) morphologic criteria (i.e. 'traditional' criteria) and Kruger's Tygerberg criteria (i.e. 'strict' criteria) . The traditional criteria stipulates a minimum 30% normal forms, using parameters based on multinational observational study data, and are more liberal than the strict criteria (World Health Organization, 1992; Rothmann et al., 2013) . The strict criteria stipulates a minimum of 4% normal forms; however, the definition of 'normal' is more conservative than the traditional criteria, using parameters based on post coital in vivo data (Kruger et al., 1988; Menkveld and Kruger, 1995) .
The sperm chromatin structure assay (SCSA w ) for DNA stability was conducted using a Coulter Epics Elite Flow Cytometer (SCSA Diagnostics, Brookings, SD, USA) following dilution of whole semen in TNE buffer (Evenson, 2013) . SCSA w measures DNA damage, which is then quantified as the DNA fragmentation index (DFI), describing the percentage of damaged DNA, and as % high stainability, describing the percentage of immature sperm nuclei with abnormal proteins (Evenson, 2013) .
All semen analyses were conducted according to NIOSH Standard Operating Procedures quality assurance guidelines and in compliance with American Society of Andrology quality control parameters (American Society of Andrology, 1996) . Data were inspected and Westgard rules (Westgard et al., 1981) implemented to ensure the absence of batch related differences and laboratory drift. Complete analysis was conducted on the first semen specimen and an abridged analysis was conducted on the second semen specimen, assessing only volume, viability, total count, concentration, motility, and sperm head morphology.
Urine phthalate assessment
Urine and blood specimens were shipped on dry ice to the Wadsworth Center, New York State Department of Health (Albany, NY, USA) for laboratory analysis. Phthalate monoester metabolites in urine were determined using high-performance liquid chromatography with electrospray triple-quadrupole tandem mass spectrometry (HPLC-MS/MS) according to previously described methods (Guo et al., 2011; Buck Louis et al., 2014) . We determined 14 phthalate monoesters (ng/ml), including: MEHP, mono-[(2-carboxymethyl)hexyl] phthalate (MCMHP), mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono (2-ethyl-5-oxohexyl) phthalate (MEOHP), mono (2-ethyl-5-carboxypentyl) phthalate (MECPP), mono-methyl phthalate (MMP), MEP, mono (3-carboxypropyl) phthalate (MCPP), monooctyl phthalate (MOP), mono-isononyl phthalate (MNP), mono (2-isobutyl) phthalate (MiBP), MBP, monocyclohexyl phthalate (MCHP), and monobenzyl phthalate (MBzP). Limits of quantification (LOQs) were determined as twice the value of the lowest valid calibration standard concentration, and ranged from 0.05-1.0 ng/ml. We quantified urine creatinine with a commercial kit using a Roche Hitachi 912 Chemistry Analyzer (Roche Diagnostics, Indianapolis, IN, USA). Serum cotinine was determined in ng/ml by HPLC-MS/MS (Bernert et al., 1997) .
Statistical analysis
We characterized the distributions of phthalate metabolites, semen parameters, and covariates, and identified outliers for further examination. We used all machine-observed phthalate concentrations without imputation of values below LOQs (Schisterman et al., 2006) . We evaluated bivariate associations among phthalates, adjusting for urine creatinine as a covariate in the model. In separate general linear models, we assessed associations between semen parameters as outcomes, and individual phthalates adjusted for a set of covariates identified a priori from the existing literature, including urine creatinine in mg/dl, age in years (Johnson et al., 2015) , body mass index in kg/m 2 (Hatch et al., 2008; Eisenberg et al., 2014) , active smoking (yes, defined as serum cotinine .10 ng/ml versus no) (Ramlau-Hansen et al., 2007; Benowitz et al., 2009) , race (white versus others), income ($50 000 -$89 999 versus , $49 999 and ≥ $90 000 versus , $49 999), and study site (Michigan versus Texas), for observations with complete information (n ¼ 375). We included abstinence time as a covariate (days) to improve model fit; it was not a confounder but is a strong predictor of semen quality (Carlsen et al., 2004) . We also constructed general linear mixed models to accommodate the use of up to 2 semen samples per man for associations between phthalates and semen volume, viability, total sperm count, sperm concentration, motility, and sperm head morphology; 378 of 473 participants (80%) provided 2 semen samples. We also looked at the additive effect of phthalates using DEHPm, the molar sum of MEHP, MCMHP, MEHHP, MEOHP, and MECPP.
Phthalates were natural log-transformed and rescaled to units of one interquartile range (IQR) to aid interpretation; regression coefficient estimates correspond to the difference in the dependent variable associated with each one IQR change in individual phthalate concentrations. We used Box-Cox transformations to the power 'k' (Supplementary Table SI 
, to achieve normality of semen quality parameters assessed by Shapiro Wilk W statistics (Handelsman, 2002) . We confirmed normality assumptions by examining residual plots. Azoospermic men (n ¼ 5) were included only for the analysis of volume, total count, and sperm concentration. Consistent with the exploratory nature of our study, we did not adjust for type-1 error inflation due to multiple comparisons, consistent with our intent to identify possible signals for future inquiry (Savitz and Olshan, 1995) . P-values ,0.05 for two-tailed tests were considered statistically significant.
Ethical approval
Study participants gave informed consent before any data collection and human subjects approval was received from all collaborating institutions.
Results
Demographic and study characteristics of participants are shown in Table I . Men were 31.8 years of age on average (range 19 -51) and mostly white (78.6%), with 59% earning at least $90 000 per year. A majority of the participants were recruited from the Texas site, and few were active smokers (n ¼ 98), as indicated by serum cotinine .10 ng/ml. Most (98.7%) men had abstained from ejaculation for at least two days prior to semen collection (median 3.0 days). There were n ¼ 5 azoospermic men, while n ¼ 7 had cryptorchidism (n ¼ 4 surgically corrected), n ¼ 2 had surgically corrected hypospadias, and n ¼ 8 had varicocele (n ¼ 2 surgically corrected).
Results of the urinary phthalates analysis are shown in Table II . Negative concentrations reflect the blank correction process used in quantification. Of the 14 monoesters, 9 were quantified above the LOQ in .95% of participants: MCMHP, MEHHP, MEOHP, MECPP, MEP, MCPP, MiBP, MBP and MBzP. Levels of MOP, MNP and MCHP were above quantification limits in ≤5% of the study sample. MEP had the highest median concentration overall (86.4 ng/ml), followed by MECPP (20.4 ng/ml), MCMHP (18.5 ng/ml) and MEHHP (15.2 ng/ml). As shown in Supplementary Table SII, we detected a range of moderate to strong creatinine-adjusted correlations among the DEHP metabolites MEHP, MCMHP, MEHHP, MEOHP and MECPP (r ¼ 0.44 -0.94, P , 0.001), while the DBP metabolites MBP and MiBP were moderately correlated (r ¼ 0.51, P , 0.001).
Results for the regression analysis of the relations of continuous phthalate metabolites with semen parameters, adjusted for age, cotinine, and other covariates are shown in Tables III -V and summarized graphically in Table VI ; we presented the quantitative results for the 14 phthalate monoesters in three tables according to parent diester molecules for clarity. Multiple phthalates were associated with lower total sperm count, including higher concentrations of MCMHP (22.89 × 10 Table SIII) .
We assessed several aspects of the morphology of the sperm head and overall in association with higher phthalate concentrations, as shown in Tables III-V ) and width (0.16 mm), and with longer perimeter (0.53 mm). We detected multiple associations for sperm morphology parameters as well. MCMHP was associated with a lower proportion of normal sperm using Kruger's strict (23.33%) and the WHO (29.67%) criteria, more amorphous (0.75%) and megalo head sperm (0.72%), more sperm with cytoplasmic droplet (0.89%), and more immature sperm (0.90). We also detected a higher proportion of megalo head sperm in association with MEHHP (0.49%) and MECPP (0.54%), and a larger number of immature sperm was further detected in association with higher MMP (0.93) and MEP (0.69). Higher MNP was associated with less normal sperm by strict (25.74%) and WHO (219.78%) criteria, with more amorphous sperm (1.23%), and with more cytoplasmic droplet sperm (1.71%). Higher levels of MiBP (1.21%) and MBP (1.23%) were associated with more pyriform sperm. The impact of DEHPm on sperm head morphometry and overall morphology approximated results for the individual constituent DEHP metabolites, though with diminished point estimates (except for sperm head perimeter) and fewer significant findings (Supplementary  Table SIII) . No associations were indicated for phthalates and our two measures of sperm chromatin stability (data not shown).
Discussion
In this sample of men recruited from the general population upon planning to try for pregnancy, we identified a pattern of diminished semen quality in association with higher concentrations of urinary phthalate monoesters. In particular, higher levels of DEHP metabolites, including MCMHP, MEHHP, MEOHP, and MECPP, as well as MMP, a metabolite of di-methyl phthalate (DMP), and MNP, a metabolite of DNP, were associated with lower motility and with altered sperm head and morphology. Effects for DEHPm were similar to those for individual DEHP metabolites, yet with attenuated impacts and reduced precision, underscoring the importance of assessing individual phthalates. We detected additional, isolated effects for MEP and MCPP 20.97, 0.76) di-octyl phthalate (DOP), respectively. MEHP was unexpectedly associated with higher sperm motility in our study, and we found no associations between MBP and motility or for sperm chromatin. Still, given the number of statistical tests, we the possibility of chance findings is important to acknowledge. Associations of urinary phthalates with human semen quality have been assessed most commonly in clinical populations, recruiting male partners of couples undergoing infertility treatment (Hauser et al., 2006; Wirth et al., 2008; Liu et al., 2012; Toshima et al., 2012; Jurewicz et al., 2013) . In studies of clinical populations, higher levels of phthalates including MBP have been observed to be related to lower sperm motility (Hauser et al., 2006; Jurewicz et al., 2013) and lower sperm concentration (Hauser et al., 2006; Liu et al., 2012) . Measures of DNA damage, including comet extent, tail-distributed moment, and % fragmentation, have also been seen with higher urinary MEP, MEHHP, and adjusted MEHP (Hauser et al., 2007) . Despite detecting numerous functional changes, we did not observe associations of phthalate metabolites with measures of DNA damage, which might be related to misclassification if in utero exposure at the time of testes development is important (Sharpe, 2006) , or possibly is a consequence of the lower prevalence of measures of this outcome in a general population.
To the best of our knowledge, this study is the most comprehensive assessment of phthalates and semen quality in a non-clinical population conducted to date. The findings of lower sperm concentration, diminished motility, and a higher proportion of abnormal morphology are consistent with those from some clinical populations that report adverse associations between phthalates and semen quality (Kay et al., 2014) . Only three prior studies have described the impact of urine phthalates on semen quality among men recruited from general, non-clinical populations. A Swedish study of 234 young military conscripts (Jö nsson et al., 2005) reported 8.8% lower sperm motility in association with higher urine MEP at median levels higher than ours (240 ng/ml), and no associations for measured MEHP (,15 ng/ml), MBP (78 ng/ml), or MBzP (16 ng/ml), or for their assessment of sperm concentration and chromatin integrity. In a large study of young Danish men (n ¼ 881), no consistent associations were detected for 14 urinary phthalate monoesters or their sums and semen volume or sperm concentration, count, motility, or morphology (Joensen et al., 2012) . The median levels of MEHP (4.0 ng/ml), MEHHP (23 ng/ml), MEOHP (14 ng/ml), MCPP (5.0 ng/ml), MOP (0.1 ng/ml), MNP (0.6 ng/ml), MiBP (58 ng/ml), MBP (28 ng/ml), and MBzP (34 ng/ml) in that study were higher or similar to values in our study, while median levels of MECPP (15 ng/ml) and MEP (78 ng/ml) were lower than ours. More recently, no associations were reported for semen volume, for sperm concentration, motility, or morphology, or for sperm chromatin measures, with urine phthalates in 232 Chinese men (Han et al., 2014) . Whereas the median MEHP level in that study (1.10 ng/ml) was similar to ours, their median MEP level (3.10 ng/ml) was lower and their median MBP level (18.72 ng/ml) was higher than our measurements.
The three previous studies of urinary phthalates and semen quality in general population samples assessed a limited panel of quality parameters; thus, modest effects may have been missed (Jö nsson et al., 2005; Joensen et al., 2012; Han et al., 2014) . While the Danish study measured a comprehensive panel of primary and secondary urinary phthalate metabolites, the Swedish and Chinese studies captured exposure to only four primary, hydrolytic phthalate monoesters. Because of the large number of metabolic products of phthalate diesters, and variation in . 23 (20.59, 1.06) 0.34 (20.79, 1.46) 0.39 (20.60, 1.38) 0.47 (20.31, 1.26) Taper (%) 20. 26 (21.03, 0.51) 20.42 (21.42, 0.57) 0.07 (21.02, 1.17) 0.03 (20.77, 0.82) Megalo head (%) 0. 08 (20.50, 0.66) 0.06 (20.70, 0.81) 0.61 (20.20, 1.43) 0.19 (20.43, 0. 57 (20.57, 1.71) 0.75 (20.47, 1.98) 0.44 (20.47, 1.35) Note: Estimates generated using linear or mixed linear regression models adjusted for age, race, body mass index, income, serum cotinine, urine creatinine, abstinence time, and study site. 
Note: Significant effects detected for 14 phthalate monoesters with 34 semen parameters (no effects detected for MOP or for viability (%), straight line velocity (mm/s), beat cross frequency (Hz), acrosome area of head (%), round sperm (%), bicephalic sperm (%), taper sperm (%), neck or midpiece abnormality (%), coiled tail (%), or other tail abnormalities (%). Effects generated using linear or mixed linear regression models adjusted for age, race, body mass index, income, serum cotinine, urine creatinine, abstinence time, and study site. Analysis for volume, total count, and concentration included n ¼ 5 azoospermic men. Assessed only in the baseline semen sample.
-, no significant effect; , significant increase (P , 0.05); , significant decrease (P , 0.05).
the half-lives of phthalate monoesters, measurement of a large panel of monoesters may be better able to capture phthalate exposure than is assessment of only primary metabolites (Koch and Calafat, 2009 ). Our comprehensive analysis of 14 primary and secondary phthalate monoester metabolites as predictors of 34 semen quality indicators in a general population offers improved insight into subtle associations unavailable to prior investigators. A growing number of publications report oxidative stress (OS) induced damage to male reproductive organs in association with phthalates exposure, and spermatozoa with high concentrations of polyunsaturated fatty acids appear to be especially vulnerable to OS-induced lipid peroxidation (Lenzi et al., 2000) . Even at low, environmentally relevant doses, MBP and MEHP elicit destruction of Sertoli tight cell junctions in vitro (Zhang et al., 2008) . Higher OS and OS-associated DNA damage has also been reported by epidemiologic studies of phthalate exposures (Kadiiska et al., 2005; Hong et al., 2009) . In an earlier LIFE study, urine 8-hydroxy-2 ′ -deoxyguanosine levels were positively correlated to urine MEHP (r ¼ 0.59, P ¼ 0.000) and MiBP (r ¼ 0.10; P ¼ 0.033) in men (Guo et al., 2014) . In the current analysis, we describe previously unreported associations for urine MCMHP, MEHHP, MECPP, MMP, MiBP, and MBzP with sperm head parameters, possibly indicative of disrupted spermiogenesis, the transformation of spherical spermatids into elongated spermatozoa (Hess and de Franca, 2008) . Still, mechanisms by which phthalates may impact semen quality in humans remain unclear.
Our work has several important limitations including phthalate levels measured using a single baseline urine specimen for exposure assessment. Misclassification is a concern related to the short in vivo half-lives of phthalates (Anderson et al., 2001) . Nevertheless, in assessment of temporal stability of phthalate metabolite measures, a single spot urine was moderately predictive of overall three month averages in men (Hauser et al., 2004) , corresponding to the cycle of human sperm production and maturation (Hess and de Franca, 2008) . Additional studies have reached similar conclusions for women (Hoppin et al., 2002) , although indicating lower reliability for DEHP metabolites (Peck et al., 2010) . Misclassification related to this kind of temporal variability represents a bias that would tend to be toward the null hypothesis. Longer term temporal trends have been observed related to US industry substitutions for DEHP, DBP, and BBzP (Zota et al., 2014) , and may help to explain the low exposure levels observed in LIFE study participants. In fact the levels in our study were generally lower than those reported for US men overall (CDC, 2015) . Temporal trends, along with geographic and population-specific differences, would not impact our findings, but likely contribute to the different results across studies. Also of note, we used a next day semen analysis approach, given the logistical challenges associated with our study conducted outside of a clinical setting. This strategy has been successful in prior studies (Royster et al., 2000) , yielding reliable information for most semen parameters of interest (Stovall et al., 1994; Morris et al., 2003) . Although some sperm survive past 24 h (Stovall et al., 1994) and refrigerated samples maintain sperm chromatin structure (Morris et al., 2003) , our next day motility end-points need to be cautiously interpreted, given the absence of established validity for interpreting findings as with clinical semen analysis.
Phthalate metabolites may impact male obesity (Hatch et al., 2008) ; associations among overweight and obese men might differ from associations in normal weight men. Men in our sample were skewed toward higher BMI (83% overweight/obese), not dissimilar to the high proportion (69%) reported for US men overall (National Center for Health Statistics, 2015) . Still, higher phthalate levels tend to be associated with higher BMI, and so we suggest caution in generalizing our results to men with normal BMI.
We conducted a large number of statistical tests, consistent with our focus on individual phthalate monoesters and detection of signals for associations with a comprehensive panel of semen quality parameters. We fully explored our data to assess previously reported associations and to identify signals to guide new research directions (Goldberg and Silbergeld, 2011) . Taken together, these findings suggest a general pattern of lower motility, larger sperm head, and more abnormal forms in association with higher urine phthalates, lending credibility to our analysis. Still, an inflated type-1 error rate might manifest as false-positive findings, and significant associations reported herein may result from chance.
In conclusion, our results suggest that phthalate diesters may negatively impact semen quality, even at low exposure levels in the general population. These associations are consistent with our earlier report of diminished couple-level fecundability in association with higher levels of male urine phthalate monoesters . Given the widespread nature of phthalates, even subtle effects on semen quality would have substantial implications at the population level for public health, as well as increased health care costs; a recent European Union sanctioned report suggests phthalates may represent a cost of E4.71 billion in annual assisted reproductive technology expenses (Hauser et al., 2015) . Further research clarifying phthalate effects on reproductive health and to establish thresholds for adverse reproductive effects is merited given the magnitude of the potential public health impact.
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